Prognostic value of N-terminal Pro–B-Type natriuretic peptide in patients with intermediate coronary lesions

BACKGROUND: The optimal treatment strategy for patients with coronary intermediate lesions, defined as diameter stenosis of 50–70%, remains a great challenge for cardiologists. Identification of potential biomarkers predictive of major adverse cardiovascular events (MACEs) risk may assist in risk st...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Chenxi, Yuan, Sheng, Cui, Kongyong, Cai, Zhongxing, Zhang, Rui, He, Jining, Qiao, Zheng, Bian, Xiaohui, Wu, Shaoyu, Wang, Haoyu, Fu, Rui, Wang, Chunyue, Liu, Qianqian, Yin, Dong, Jia, Lei, Dou, Kefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370998/
https://www.ncbi.nlm.nih.gov/pubmed/35966554
http://dx.doi.org/10.3389/fcvm.2022.903757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370998/
https://www.ncbi.nlm.nih.gov/pubmed/35966554
http://dx.doi.org/10.3389/fcvm.2022.903757

Ejemplares similares